Forte Biosciences (NASDAQ:FBRX) focuses on advancing the science and treatment of patients battling inflammatory skin diseases. Using a combination of biotechnology and a deep understanding of dermatological conditions, Forte is committed to developing innovative therapies. The company's projects primarily revolve around leveraging their proprietary technology platforms to create treatments that are both effective and safe for patients suffering from conditions such as psoriasis, atopic dermatitis, and other inflammatory skin diseases. At the core of Forte's objectives, is the ambition to significantly improve the quality of life for patients by offering novel solutions that address unmet clinical needs in the dermatology space. Their efforts are directed towards not only discovering and developing new drugs but also ensuring these advancements are accessible to the individuals who need them most.